PharmiWeb.com - Global Pharma News & Resources
03-Apr-2019

Molecular Diagnostics Market Worth Around 15.6 Billion USD by 2024 | Vigorous CAGR 11% In Global Market

Global Molecular Diagnostics Market was valued at USD 7.5 billion in 2017 and is likely to generate a demand of USD 15.6 billion by 2024, at a vigorous CAGR of 11% over the forecast period.

The growth in the market is attributed to the growing number of infectious diseases and chronic diseases across the globe, improving reimbursement scenario, and increasing adoption of advanced diagnostic techniques. Moreover, the growing increase in collaborative diagnostic programs and increasing investments in diagnostic healthcare is further propelling the industry growth. The years used for the assessment are as follows:

Historical year: 2014, 2015 and 2016

Base year: 2017

Forecast period: 2018 ndash; 2024

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/11461

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total global molecular diagnostics market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global molecular diagnostics market
Finalizing the overall size and share of the global molecular diagnostics market

OBJECTIVES:

To analyze market trends, opportunities, drivers, and restraints associated with the global molecular diagnostics market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the global molecular diagnostics market and provide their competitive landscape

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/global-molecular-diagnostics-market-emr-11461

MARKET SCOPE

The research scope for global molecular diagnostics market is as follows:

Product and Service
Instruments
Reagents and Kits
Services and Software

Technology
DNA Sequencing and Next-Generation Sequencing (NGS)
DNA Microarray
Fluorescent in Situ Hybridization
Nucleic Acid Amplification (NAT)
Polymerase Chain Reaction (PCR)
Other

Application
Infectious Disease
Virology
HIV viral load
HCV viral load
HBV viral load
CMV viral load
HPV
HSV
EBV
influenza A/B
others
Bacteriology
Chlamydia
Gonorrhea
pertussis
Methicillin-resistant Staphylococcus aureus (MRSA)
CT/NG
Healthcare Acquired Infections (HAIs)
Genomics Testing
Inherited Disorders
Human Leukocyte Antigen(HLA) testing
Pharmacogenetics
Blood Donor Screening
Oncology
Colorectal cancer
Pancreatic cancer
Brain cancer
Kidney cancer
Thyroid cancer
Breast cancer
Lung cancer
Melanoma
Prostate cancer
Precancer
Leukemia
Lymphoma
Bladder cancer
Cervical cancer
Chest cancer

End-user
Laboratories
Hospitals
Other

By Region
North America
Europe
Asia-Pacific
Central amp; South America
Middle East and Africa (MEA)

Enquiry Before Buying: http://www.amecoresearch.com/enquiry-before-buy/11461

FREE ANALYSIS

Molecular diagnostics play an important role in understanding the pathogenesis of various diseases, as well as in their diagnosis and treatment. The healthcare system is critically and crucially dependent upon diagnostics. Molecular diagnostics has transformed diagnosis dynamically by providing insights into the treatment of various diseases. Molecular diagnostics market represents a relatively new era in medicine that offers benefits of detecting diseases at an early stage. The major factors driving the growth are increasing incidences of chronic diseases, and the ongoing fight against cancer and other illnesses.

Geographically, North America held the largest share of the market in 2017. The growth in the region is attributed to the increasing elderly population, rising incidence of chronic diseases, and growing development in pharmacogenomics. Moreover, the growing demand for infectious disease testing and the presence of major player in the region is further boosting the market growth. Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to growing investment in the healthcare diagnostics, and increasing adoption of molecular diagnostics test.

Some of the key companies operating in the market include QIAGEN , HTG Molecular Diagnostics, Inc., Abbott Laboratories , bioMeacute;rieux SA, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd), Becton, Dickinson and Company, Hologic Inc., Cepheid, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Genetic Signatures Ltd among others.

Major Points From Table Of Contents

Global Molecular Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation amp; Forecast 2024

CHAPTER 1. Market Scope and Methodology

CHAPTER 2. Executive Summary

CHAPTER 3. Industry Analysis

CHAPTER 4. Competitive Outlook

CHAPTER 5. Global Molecular Diagnostics Market Size and Forecast (2014 ndash; 2024)

CHAPTER 6. Global Molecular Diagnostics Market, By Geography

CHAPTER 7. Key Players and Strategic Developments

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11461

Editor Details

Last Updated: 15-Apr-2019